| Website | versartis.com |
| Category | BioTech |
| Employees | |
| Founded | 12/08 |
| Description | Therapeutics Protein Developer |
| Total | $32M |
| Series A, 6/09 Index Ventures | $11M |
| Series B, 2/11 New Leaf Venture Partners Advent Venture Partners Index Ventures | $21M |
Versartis is a biotechnology company developing therapeutic proteins for the treatment of metabolic diseases and endocrine disorders. The company was founded in December 2008 as a joint venture between Amunix and Index Ventures.
